HemOnc Today

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents
Commentary

When worlds collide: Chemotherapy near the end of life

Arif H. Kamal, MD

Back to the future: Chemotherapy dosing in overweight and obese patients with cancer

Gary H. Lyman, MD MPH

Interim DeCOG results provide reassurance for patients who delay CLND after positive sentinel node

Vernon K. Sondak, MD

Cover Story

Immunotherapy ‘revolutionary’ for lung cancer, but questions remain about cost, biomarkers

Editorial

Research reveals fine line between ‘one more try’ and ‘a bridge too far’

John Sweetenham, MD

FDA News

FDA grants breakthrough drug designation to Lenvima for advanced RCC

FDA expands approval of Kyprolis for relapsed multiple myeloma

FDA approves Odomzo for locally advanced basal cell carcinoma

FDA grants orphan drug designation to Anisina for neuroblastoma

FDA grants orphan drug designation to Ad-RTS-hIL-12 for malignant glioma

FDA grants breakthrough therapy designation to Azedra for pheochromocytoma, paraganglioma

In the Journals

Vitamin D levels may affect follicular lymphoma outcomes

Radioactive iodine for thyroid cancer may not increase breast cancer risk

Vena cava filter as anticoagulation add-on did not reduce symptomatic recurrent pulmonary embolism

Pegylated interferon alfa-2b provides minimal benefit as maintenance therapy for osteosarcoma

One-third of women with breast cancer desire genetic testing

Palliation should be comparable for patients with hematologic malignancies, solid tumors

Palliative chemotherapy fails to improve quality of life near death

Treatment of stage I breast cancer has intensified over time

Routine CT does not improve occult cancer detection after unprovoked VTE

Researchers find HBV screening rate low in patients undergoing chemo

Researchers identify factors that increase mortality risk among patients with MPNs

Statin use before ADT delays prostate cancer progression

Systemic therapy underutilized in NSCLC treatment, particularly among older patients

Surveillance imaging offers little benefit for DLBCL in first remission

Support, survivorship concerns unmet in thyroid cancer

Breast, ovarian cancer risks vary by BRCA mutation location, type

BMI should not influence chemotherapy dose reductions for ovarian cancer

Fever present in HHV-6 reactivation after pediatric stem cell transplant

Certain biomarkers predict anthracycline chemotherapy benefit in breast cancer

Comorbidities increase risk for lung cancer mortality

Conditional survival estimates valuable for intrahepatic cholangiocarcinoma

Early initiation of palliative care offers benefits to patients, family caregivers

Mastectomy with immediate reconstruction doubles risk for SSI

Indoor tanning rates decline among US adults

Gene assay predicts recurrence following nephrectomy in renal cell carcinoma

Bladder cancer risk not increased with pioglitazone therapy

Institution Notes

ASTRO elects three new board members

Center for Childhood Cancer and Blood Disorders appoints director

MD Anderson Cancer Center named best cancer hospital in nation

Meeting News Coverage

Radiation exposure from mammography screening may have been overestimated

Exome sequencing found to assist in determining HCC therapy

Change in radiation dose distribution may reduce late rectal bleeding

morganatic-roan
morganatic-roan